A Study of Oral Ixazomib Maintenance Therapy in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Not Treated With Stem Cell Transplantation (SCT)
Clinical trial NCT02312258 · COMPLETED
Trial details
- NCT number
- NCT02312258
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-09
- Primary completion
- 2019-08-12
- Enrollment
- 706
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.